NCT04741828View on ClinicalTrials.gov

Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

October 28, 2024

Study Completion Date

December 30, 2024

Conditions
Vaccine
Interventions
DRUG

Vi-DT Typhoid Conjugate Vaccine

Typhoid Conjugate Vaccine

Trial Locations (2)

Unknown

Puskesmas Jatinegara, Jakarta

Puskesmas Senen, Jakarta

Sponsors

Lead Sponsor

PT Bio Farma
All Listed Sponsors
collaborator

Indonesia University

OTHER

lead

PT Bio Farma

INDUSTRY